Results of Treatment With Hypomethylating Agents Versus Hypomethylating Agents/Venetoclax in Patients With AML Single-Center Experience

被引：0
|
作者：
Patino, Ana Flavia [1 ]
Brulc, Erika [1 ]
Conca, Alberto Gimenez [1 ]
机构：
[1] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
AML; survival; hypomethylating agents; venetoclax;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-032
引用
收藏
页码：S289 / S289
页数：1
相关论文
共 50 条
  • [1] THE EXPERIENCE OF A SINGLE CENTER OF HEMATOLOGY IN THE TREATMENT WITH HYPOMETHYLATING AGENTS
    Georgescu, D.
    Popescu, M.
    Tevet, M.
    Patrinoiu, O.
    Murat, M.
    Ciuhu, A.
    LEUKEMIA RESEARCH, 2015, 39 : S95 - S96
  • [2] Venetoclax combined with hypomethylating agents and the CAG regimen in relapsed/refractory AML: a single-center clinical trial
    Liu, Yifan
    Li, Yanfen
    Zhang, Ran
    Yu, Zhangyu
    Jing, Yu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] Clinical Results of Hypomethylating Agents in AML Treatment
    Cruijsen, Marjan
    Luebbert, Michael
    Wijermans, Pierre
    Huls, Gerwin
    JOURNAL OF CLINICAL MEDICINE, 2015, 4 (01): : 1 - 17
  • [4] The highs and lows of venetoclax with hypomethylating agents for refractory AML
    Brunner, Andrew M.
    LEUKEMIA RESEARCH, 2020, 91
  • [5] Combination of Venetoclax and Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: Single-Center Clinical Experience
    Secilmis, Sema
    Bozan, Ersin
    Darcin, Tahir
    Yaman, Samet
    Yigenoglu, Tugcenur
    Ulu, Bahar Uncu
    Sahin, Derya
    Bakirtas, Mehmet
    Basci, Semih
    Yildiz, Jale
    Baysal, Nuran Ahu
    Iskender, Dicle
    Cakar, Merih Kizil
    Sinan, Dal Mehmet
    Altuntas, Fevzi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S192 - S193
  • [6] Hypomethylating agents use in acute myeloid leukemia: A single-center experience
    Bodepudi, Sravan Kumar
    Devdas, Santhosh Kumar
    Maka, Vinayak V.
    Palassery, Rasmi
    Hiregoudar, Sumathi S.
    Kilara, Nalini
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (02) : 202 - 208
  • [7] Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML
    Ucar, M. A.
    Ozet, G.
    Koyuncu, M. B.
    Sonmez, M.
    Akidan, O.
    Ayli, M.
    Yildirim, M.
    Pehlivan, M.
    Akkurt, D. M.
    Sahin, H.
    Guvenc, B.
    Okan, V
    Tiftik, E. N.
    Akdeniz, A.
    Dincyurek, H. D.
    Gunes, A. K.
    Dagdas, S.
    Acar, H., I
    Ucar, H. K.
    Tombak, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (21) : 6557 - 6565
  • [8] The role of hypomethylating agents in the treatment of elderly patients with AML
    Al-Ali, Haifa Kathrin
    Jaekel, Nadja
    Niederwieser, Dietger
    JOURNAL OF GERIATRIC ONCOLOGY, 2014, 5 (01) : 89 - 105
  • [9] Treatment Outcomes with Hypomethylating Agents and Venetoclax for AML in the Community Compared to an Academic Setting
    Jeffrey, Lantz, Jr.
    Pham, Natalie
    Jones, Caroline
    Kundu, Debamita
    McCann, Nicholas
    El Chaer, Firas
    Reed, Daniel
    Keng, Michael
    BLOOD, 2023, 142
  • [10] Venetoclax combined with hypomethylating agents for favorable risk acute myeloid leukemia: A single center experience
    Bajwa, Shammas
    Parkin, Brian
    Gayle, Arlene A.
    Patel, Rushang D.
    Mori, Shahram
    Pancari, Philip
    Socola, Francisco Andres
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345